Huarong Holdings: terminate the purchase of 100% equity of Xinchao biology and resume trading tomorrow
Financial Associated Press, Dec. 28 - Huarong holdings announced that the counterparty reached an agreement on non employment performance commitment and compensation, terminated the purchase of 100% equity of Shanghai Xinchao Biotechnology Co., Ltd., and the trading of the shares has resumed since the opening of the market on December 29, 2021.
This text is a result of machine translation.
Related companies：
In-depth
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Nov 08, 2022 08:32 AM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Technology, Financials
Kingsoft Cloud Q4 2022 Achieve Revenue CNY 2.13 billion, Down 19.9% YOY
With the iteration of the large generic model, AI field is likely to continue to develop rapidly, if Kingsoft Office to build their own models and algorithms, building WPS from office software into a new generation of AI assistant, then it is also a great advantage for Kingsoft Cloud(Chinese: 金山云).
Mar 30, 2023 11:51 PM
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Consumer Staples
Can Douyin Grab a Slice of The Food Delivery Market From Meituan?
Mar 30, 2023 06:12 PM
Insight
In-depth
Healthcare
Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery
Mar 30, 2023 04:00 PM
Insight
In-depth